Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Response Acquires Oncotech's Cryo-preserved Human Cancer Tissue Bank

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Response this week announced it has acquired the world's largest cryo-preserved human cancer tissue bank formerly owned by Oncotech.

In addition, it has acquired de-identified clinical information and validated test procedures and secured related test validation protocols for molecular characterization of the samples as part of the deal.

Financial and other terms of the deal were not disclosed.

Oncotech was acquired in 2007 by Exiqon, which decided in December that it would be divesting the Tustin, Calif.-based cancer diagnostics company. In June, Exiqon decided to shut down Oncotech after Medicare declined coverage of its EDR tests.

The tissue bank acquired by Molecular Response contains more than 144,000 discrete cancer samples preserved as living single-cell suspensions, stored at minus-180 degrees Celsius. Each specimen has been profiled against a panel of drugs so that researchers can select tumor cells of interest based on sensitivity and/or resistance profiles, the San Diego-based company said.

It added that the size of the bank allows drug makers to screen and select for cancers that have specific molecular characteristics and to study the effects of the drugs on those specific cases.

"Our acquisition of this incredible tumor bank and associated clinical information provides a unique platform for our collaborators in both pre-clinical and clinical applications," said Molecular Response CEO Cyrus Mirsaidi. "In concert with our biopharma partners we can select what disease targets to avoid for new drug candidates and pick the best new cancer indications for experimental drugs to maximize clinical trial budgets."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.